Should patients with advanced lung cancer and difficulty breathing receive oxygen therapy?
In general, patients with advanced lung cancer who experience difficulty breathing require oxygen therapy. The specific analysis is as follows:
When patients with advanced lung cancer develop dyspnea (difficulty breathing), oxygen supplementation is needed to increase oxygen flow and help alleviate their respiratory symptoms. However, whether this approach is effective clinically depends on a comprehensive assessment of various factors, including tumor-specific conditions, lung function, presence of inflammatory manifestations, or complications such as pulmonary embolism. Careful analysis and judgment are required in each case. If the breathing difficulty is caused by significant tumor compression, oxygen therapy may be provided, provided the patient is not in the terminal stage. However, the primary treatment should focus on managing the tumor itself. Effective anti-tumor treatment may relieve the compressive symptoms, thereby naturally improving the patient's breathing. If inflammation is present, the patient’s respiratory status may improve with anti-inflammatory and anti-infective treatments, along with oxygen therapy and symptomatic management. Patients may take medications such as amoxicillin tablets or cefuroxime sodium for injection under medical guidance.
If patients experience any discomfort, they are advised to seek timely medical attention at a hospital to avoid delays in diagnosis and treatment.